Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
122.21
-3.75 (-2.98%)
Apr 29, 2026, 2:57 PM EDT - Market open
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.75 billion as of April 29, 2026. Its market cap has increased by 629.57% in one year.
Market Cap
1.75B
Enterprise Value
1.70B
1-Year Change
629.57%
Ranking
Category
Stock Price
$122.21
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.75B, an increase of 1,115.03%. That is a compound annual growth rate of 523.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.80B | 45.53% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.92B |
| AnaptysBio | 1.91B |
| Galapagos NV | 1.89B |
| Vericel | 1.88B |
| Pharvaris | 1.88B |
| Taysha Gene Therapies | 1.86B |
| Syndax Pharmaceuticals | 1.85B |
| Recursion Pharmaceuticals | 1.84B |